We’re proud to announce that Cyber Surgery has started the last preclinical trials in human cadavers with our high precision surgical robot. This is exciting news as it means we are one step closer to getting the approval from the Spanish Medicines Agency for performing clinical trials in real patients.
The Spanish Medicines Agency (AEMPS) fosters scientific excellence in the evaluation and supervision of medicines, for the benefit of public health in Spain. After this big step, our robotic assistant can be evaluated by The Spanish Agency to authorize it for clinical research. This is of great importance as the AEMPS’s evaluations of marketing-authorization applications provides the basis for the authorization of medicines in Spain.
Robotic Assisted Surgery Preclinical Trials in BioDonostia
The last preclinical studies to be performed in bodies will be located at the Health Research Institute BioDonostia and with the collaboration of BIOEF. The trials with the Cyber Surgery’s robot will be performed by Dr. Nicolás Samprón, Neurosurgeon at Osakidetza and researcher at Instituto de Investigación Sanitaria Biodonostia and also by Dr. Iñigo Pomposo, Neurosurgeon at Osakidetza and researcher at Instituto de Investigación Sanitaria BioCruces.
The preclinical trials to be evaluated by the AEMPS will bring our high precision surgical robot one step closer to market commercialization. Stay with us as our robotic innovation in Health Tech marches forward!